Picture of Pegavision logo

6491 Pegavision Share Price

0.000.00%
tw flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Momentum

Relative Strength (%)
1m-6.84%
3m+6.45%
6m+13.02%
1yr+40.58%
Volume Change (%)
10d/3m-6.74%
Price vs... (%)
52w High-14.96%
50d MA-4.43%
200d MA+12%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)15.98
PEG Ratio (f)1.09
EPS Growth (f)17.21%
Dividend Yield (f)2.81%
Valuation (ttm)IndustryMarket
Price to Book Value3.77
Price to Tang. Book3.77
Price to Free Cashflown/a
Price to Sales5.15
EV to EBITDA11.15

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital20.53%
Return on Equity23.26%
Operating Margin30.09%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueTWDm3,355.133,978.415,595.046,321.26,789.867,753.518,664.5616.73%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-18.59+33.98+73.59+24.01+4+19.59+14.85n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Pegavision EPS forecast chart

Profile Summary

Pegavision Corp is primarily engaged in the manufacture and sale of private brand contact lenses, as well as the original equipment manufacturing (OEM) business. The Company distributes its products within domestic market and to overseas markets.

Directors

Last Annual
December 31st, 2023
Last Interim
March 31st, 2024
Incorporated
August 26th, 2009
Public Since
December 30th, 2014
No. of Employees
589
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
tw flag iconTaiwan Stock Exchange
Shares in Issue
78,000,000

6491 Share Price Performance

Upcoming Events for 6491

Dividend For 6491.TW - 10.0000 TWD

Q2 2024 Pegavision Corp Earnings Release

Q3 2024 Pegavision Corp Earnings Release

Similar to 6491

Picture of Apex Biotechnology logo

Apex Biotechnology

tw flag iconTaiwan Stock Exchange

Picture of Wellell logo

Wellell

tw flag iconTaiwan Stock Exchange

Picture of Bionime logo

Bionime

tw flag iconTaiwan Stock Exchange

Picture of CHC Healthcare logo

CHC Healthcare

tw flag iconTaiwan Stock Exchange

Picture of Excelsior Medical Co logo

Excelsior Medical Co

tw flag iconTaiwan Stock Exchange

FAQ